For the twelfth consecutive year, Challenges has published its selection of "100 start-ups to invest in".
The start-ups created and supported by Erganeo EverZom, SkinDermic and SideROS, are included this year in the Medtech and Biotech sector.
SkinDermic is specialized in the development of innovative drugs for the treatment of infectious and inflammatory skin diseases.
Everzom is a start-up specialized in the field of regenerative medicine, and develops an innovative process for the production of extracellular vesicles (EVs).
SideROS develops new molecules to fight cancer.
More than ever, Erganeo believes in them and congratulates them warmly.
To know more about
